Document is current
Any future updates will be listed below
-
Authors
Hanson, James V. M. http://orcid.org/0000-0003-3383-4856
Ng, Mei-Yee
Hayward-Koennecke, Helen K.
Schippling, Sven
Reeve, Kelly A.
Gerth-Kahlert, Christina
-
Funding
Funding for this research was provided by:
University of Zurich (Clinical Research Priority Programme Multiple Sclerosis, Clinical Research Priority Programme Precision MS)
Bruppacher Stiftung
OPOS Stiftung
Universität Zürich
- License Information
-
More Information
Article History
Received: 22 April 2021
Accepted: 15 September 2021
First Online: 27 October 2021
Declaration
:
: James V. M. Hanson, Mei-Yee Ng, Helen K. Hayward-Koennecke, Kelly A. Reeve, and Christina Gerth-Kahlert report no conflicts of interest. Sven Schippling is supported by the Swiss MS Society, the Swiss National Science Foundation (320030_175770), and the Myelin Repair Foundation. He has received travel support and/or speaker fees from Biogen, Celgene, Merck, Sanofi/Genzyme and Alexion. He is currently an employee at Roche Pharma, Basel, Switzerland.
: The study was approved by the Cantonal Ethics Committee of Zurich (EC-No.2013–0001).
: All subjects consented in writing to participating in the study and to their data being published.
: All subjects consented in writing to participating in the study and to their data being published.
